EHRA Premium Access

Diabetes mellitus, time in the therapeutic range and adverse outcomes in patients with atrial fibrillation: insights from the AFFIRM study

Congress Session

About the speaker

Doctor Marco Proietti

University of Milan, Milan (Italy)
6 presentations
0 follower

5 more presentations in this session

Different obesity paradox of ischemic stroke without and with atrial fibrillation

Speaker: Assistant Professor Y. Baek (Incheon, KR)

Thumbnail

Usefulness of CHADS2-VASc score in predicting stroke in patients with atrial fibrillation and heart failure with preserved ejection fraction

Speaker: Doctor A. Berkovitch (Tel Hashomer, IL)

Thumbnail

Thromboembolic events associated with cardioversion of atrial fibrillation in patients randomized to antiplatelet treatment in the ACTIVE trials

Speaker: Doctor W. Mcintyre (Hamilton, CA)

Thumbnail

Prediction of Thromboembolic Events in Anticoagulated Patients with Atrial Fibrillation: Comparison of CHA2DS2-VASc and GARFIELD-AF Stroke Risk Scores

Speaker: Doctor M. Proietti (Milan, IT)

Thumbnail

Thromboembolism after electrical isolation of the left atrial appendage: a new indication for interventional closure

Speaker: Doctor S. Bordignon (Frankfurt, DE)

Thumbnail

Access the full session

Moderated ePosters 11: AF: stroke and anticoagulation

Speakers: Doctor M. Proietti, Assistant Professor Y. Baek, Doctor A. Berkovitch, Doctor W. Mcintyre, Doctor M. Proietti...
Thumbnail

About the event

Image

EHRA 2019

17 March - 19 March 2019

Sessions Presentations

This platform is supported by

logo Novo Nordisk